Mineralys Therapeutics
MLYS· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +194.8% in FY2025
Jon Congleton is the CEO of Mineralys Therapeutics and was paid $5.5M in FY2025 (Dec), up 2%.
Pay$100 in the stock at the end of FY23 → $422
Executives3
See all- 1Jon CongletonPresident and Chief Executive OfficerFY2025
- 2David Rodman, M.D.Chief Medical OfficerFY2025
- 3Adam LevyChief Financial Officer and SecretaryFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMineralys Therapeutics paid its 3 named executives $10.0M in total in FY2025 (Dec). CEO Jon Congleton was paid $5.5M of that.
| Name | |||
|---|---|---|---|
| Jon CongletonPresident and Chief Executive Officer | Not disclosed | ||
| David Rodman, M.D.Chief Medical Officer | |||
| Adam LevyChief Financial Officer and Secretary |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Mineralys Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 8, 2026 | FY2025 |
| Annual report | 10-K | Mar 12, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 9, 2025 | FY2024 |
| Annual report | 10-K | Feb 12, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 9, 2024 | FY2023 |
| Annual report | 10-K | Mar 21, 2024 | FY2023 |
